Sector Chart Glenmark Pharmaceuticals Limited Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,248.00 INR | +1.31% |
|
-0.62% | +10.42% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 6.6B | |||||
| 49.54B | |||||
| 40.07B | |||||
| 12.4B | |||||
| 11.85B | |||||
| 9.1B |
Select your edition
All financial news and data tailored to specific country editions
